Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

被引:180
|
作者
Lee, JH
Takahashi, T
Yasuhara, N
Inazawa, J
Kamada, S
Tsujimoto, Y [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Biomed Res Ctr, Dept Med Genet, Osaka, Japan
[2] Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan
[3] Tokyo Med & Dent Univ, Med Res Inst, Div Genet, Dept Mol Cytogenet,Bunkyo Ku, Tokyo 1138519, Japan
基金
日本学术振兴会;
关键词
apoptosis; Bcl-2; Bis;
D O I
10.1038/sj.onc.1203043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-2 is the best characterized inhibitor of apoptosis, although the molecular basis of this action is not fully understood. Using a protein interaction cloning procedure, we identified a human gene designated as bis (mapped to chromosome 10q25) that encoded a novel Bcl-2-interacting protein. Eis protein showed no significant homology with Bcl-2 family proteins and had no prominent functional motif. Co-immunoprecipitation analysis confirmed that Eis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Eis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing flax-induced and Fas-mediated apoptosis. These results suggest that Bis is a novel modulator of cellular anti-apoptotic activity that functions through its interaction with Bcl-2.
引用
收藏
页码:6183 / 6190
页数:8
相关论文
共 50 条
  • [31] Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells
    Low, Soon Yang
    Tan, Boon Shing
    Choo, Heng Lungh
    Tiong, Kai Hung
    Khoo, Alan Soo-Beng
    Leong, Chee-Onn
    CANCER LETTERS, 2012, 314 (02) : 166 - 175
  • [32] The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
    Borner, C
    MOLECULAR IMMUNOLOGY, 2003, 39 (11) : 615 - 647
  • [33] Bcl-2 family: Life-or-death switch
    Tsujimoto, Y
    Shimizu, S
    FEBS LETTERS, 2000, 466 (01) : 6 - 10
  • [34] BCL-2 in the crosshairs: tipping the balance of life and death
    Walensky, L. D.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (08) : 1339 - 1350
  • [35] Targeting the Bcl-2
    Patel, Mehul P.
    Masood, Aisha
    Patel, Priya S.
    Chanan-Khan, Asher A.
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (06) : 516 - 523
  • [36] Regulators of life and death: The Bcl-2 gene family
    Moroy, T
    Zornig, M
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 1996, 6 (06) : 312 - 336
  • [37] Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy
    El Dakkak, Bisan
    Taneera, Jalal
    El-Huneidi, Waseem
    Abu-Gharbieh, Eman
    Hamoudi, Rifat
    Semreen, Mohammad H.
    Soares, Nelson C.
    Abu-Rish, Eman Y.
    Alkawareek, Mahmoud Y.
    Alkilany, Alaaldin M.
    Bustanji, Yasser
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (03) : 267 - 280
  • [38] Bcl-B: an "unknown" protein of the Bcl-2 family
    Pervushin, N. V.
    Kopeina, G. S.
    Zhivotovsky, B.
    BIOLOGY DIRECT, 2023, 18 (01)
  • [39] Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: A study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell limes
    Gazitt, Y
    Hu, WX
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (01) : 211 - 220
  • [40] Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family
    S Shangary
    D E Johnson
    Leukemia, 2003, 17 : 1470 - 1481